Cargando…
Mitochondrial Quality Control in the Heart: New Drug Targets for Cardiovascular Disease
Despite considerable efforts to prevent and treat cardiovascular disease (CVD), it has become the leading cause of death worldwide. Cardiac mitochondria are crucial cell organelles responsible for creating energy-rich ATP and mitochondrial dysfunction is the root cause for developing heart failure....
Autores principales: | Oh, Chang-Myung, Ryu, Dongryeol, Cho, Sungsoo, Jang, Yangsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098821/ https://www.ncbi.nlm.nih.gov/pubmed/32216174 http://dx.doi.org/10.4070/kcj.2019.0416 |
Ejemplares similares
-
Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-Induced Heart Failure
por: Oh, Chang-Myung, et al.
Publicado: (2019) -
Comparative Transcriptome Profiling of Young and Old Brown Adipose Tissue Thermogenesis
por: Kim, Yumin, et al.
Publicado: (2021) -
Regulation of Mitochondrial Quality Control by Natural Drugs in the Treatment of Cardiovascular Diseases: Potential and Advantages
por: Chang, Xing, et al.
Publicado: (2020) -
Visit-to-visit HbA1c and glucose variability and the risks of macrovascular and microvascular events in the general population
por: Jang, Ji-Yong, et al.
Publicado: (2019) -
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
por: Wei, Shibo, et al.
Publicado: (2023)